Navigation Links
Scripps Announces Plans for Region's First Proton Therapy Center; $185 Million Facility to Offer Advanced Care to Cancer Patients
Date:6/22/2010

Scripps Health today announced plans to open the first patient care facility in San Diego County to offer advanced proton therapy to cancer patients. Groundbreaking for the $185 million Scripps Proton Therapy Center is expected in July 2010 and the facility is expected to be open for patient care by spring 2013.

Scripps Health today announced plans to open the first patient care facility in San Diego County to offer advanced proton therapy to cancer patients. Groundbreaking for the $185 million Scripps Proton Therapy Center is expected in July 2010 and the facility is expected to be open for patient care by spring 2013.

The facility will be built through a partnership among Scripps Health, Scripps Clinic Medical Group and Advanced Particle Therapy (APT), LLC of Minden, Nev. The 102,000-square-foot center will have the capacity to treat approximately 2,400 patients annually. It will be built on a seven-acre site in the Carroll Canyon area of Mira Mesa, at 9577 Summers Ridge Rd.

For certain cancers, proton therapy offers a more precise and aggressive approach to destroying cancerous and non-cancerous tumors, compared to conventional X-ray radiation. Proton therapy involves the use of a controlled beam of protons to target tumors with control and precision unavailable in other radiation therapies. The precise delivery of proton energy limits damage to healthy surrounding tissue, resulting in minimal or no side effects to the patient. This precision also allows for a more potent and effective dose of radiation to be used.

The Scripps Proton Therapy Center will be just the second proton therapy center in California and the Western United States, and is expected to attract patients from across the West.

“Scripps is excited to help provide access to one of science’s most sophisticated weapons against cancer,” said Scripps Health President and CEO Chris Van Gorder. “This will be an immensely valuable resource for all of San Diego County and beyond. We see this as a major step forward, allowing us to provide the most comprehensive range of radiation therapy options available today.”

The new facility will include five treatment rooms, three of which will include gantries, which are rotational machines designed to deliver the therapeutic beam at the precise angle prescribed by the physician. The other two treatment rooms will have fixed-beam machines. The center will also offer MRI and CT scan diagnostic services in support of proton therapy; 16 patient exam rooms; and offices for 14 physicians.

There are currently seven proton therapy patient treatment centers in the United States. They are located in Loma Linda, Calif. (opened 1990); Boston, Mass. (opened 2002); Bloomington, Ind. (opened 2004); Houston, Texas (opened 2006); Jacksonville, Fla. (opened 2006); Oklahoma City, Okla. (opened 2009); and Philadelphia, Penn. (opened 2009).

Patients will be able to access this treatment through a referral to a specialist credentialed by the Scripps Proton Therapy Center. Proton therapy has an established history of reimbursement by Medicare and private health care payers.

A non-invasive treatment, proton beam therapy is usually performed on an outpatient basis and is considered most effective on tumors that are localized and have not spread to distant areas of the body.

Scripps Health will provide clinical management services to the center, and Scripps Clinic Medical Group will oversee the medical services. APT has arranged financing to build the center and purchase the proton therapy equipment from Varian Medical Systems of Palo Alto, Calif. Additionally, APT will manage and maintain the building and equipment. The architect for the center is Haskell Design Build of Jacksonville, Fla.

Varian will equip the facility with a fully integrated proton therapy system. The center’s superconducting cyclotron will feature pencil-beam (or spot) scanning, which allows for modulation of the proton beam’s intensity. This allows doctors to precisely shape the dose distribution to concentrate on the targeted tumor while sparing normal healthy tissue.

“With only seven proton treatment centers operating in the United States, we are honored to work with Scripps to provide a state-of-the-art facility that will treat patients from San Diego and beyond,” said Jeff Bordok, president and CEO of Advanced Particle Therapy, LLC.

Nearly 70,000 people worldwide have received proton therapy at centers in Europe, Asia and the United States. Patients typically receive approximately 30 treatments during a four- to six-week period. Each treatment lasts for approximately 15-25 minutes, after which the patient is free to carry on with daily affairs.

In addition to providing patient care, Scripps expects to be at the forefront of new and developing clinical applications as part of its proton practice and connection with other national centers.

Scripps has long been a leader in providing cancer care in San Diego. It opened the county’s first blood and marrow transplantation program in 1980, and during the past 30 years the program’s patient survival rate has doubled. Scripps’ robotic surgery program currently offers patients the widest range of options in San Diego. And Scripps is the only cancer care provider in San Diego to earn network accreditation from the American College of Surgeons’ Commission on Cancer.

With more than 300 affiliated physicians, Scripps Cancer Center is a nationally recognized leader in cancer care, providing comprehensive care at its four hospitals and various Scripps Clinic locations. Scripps Cancer Center seeks to provide the best possible treatment and cutting-edge research trials for patients by coordinating medical expertise in the areas of clinical cancer care, community outreach and clinical, translational and basic research.

ABOUT SCRIPPS HEALTH

Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a $2.2 billion, private not-for-profit community health system based in San Diego, Calif. Scripps treats a half-million patients annually through the dedication of 2,500 affiliated physicians and 13,000 employees among its five acute-care hospital campuses, home health care services, and ambulatory care network of physician offices and 19 outpatient centers and clinics.

Scripps is recognized as a leader in the prevention, diagnosis and treatment of disease, and is at the forefront of clinical research and graduate medical education. More information can be found at www.scripps.org.

ABOUT SCRIPPS CLINIC MEDICAL GROUP

Scripps Clinic Medical Group is a multi-specialty physician practice with 420 physicians representing 50 medical and surgical specialties. Scripps Clinic Medical Group and its physicians are world-renowned for research-driven care and medical specialty expertise offered at 10 outpatient locations throughout the San Diego region and within Scripps Health’s network of acute-care hospitals. More information is available at www.scripps.org/clinic.

###

Read the full story at http://www.prweb.com/releases/scripps/proton/prweb4173414.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Fitch, Standard & Poor's Upgrade Scripps Health to AA-; Scripps to Issue $220 Million in Hospital Revenue Bonds
2. Scripps Health Preparing for Deployment of Medical Response Team to Haiti
3. Scripps Research scientists reveal key structure from ebola virus
4. New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla
5. Scripps Research scientists find cancer cells co-opt fat metabolism pathway to become more malignant
6. Scripps Health Begins Pioneering Study of Human Tumor Sequencing in Cancer Patients
7. Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus
8. Scripps Blood & Marrow Transplant Program Celebrates 30th Anniversary of Providing Life-Saving Care
9. Scripps Memorial Hospital La Jolla First in San Diego to Achieve Magnet Nursing Re-designation
10. Drug Information Association (DIA) Announces New Clinical Safety and Pharmacovigilance Certificate Program
11. Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scripps Announces Plans for Region's First Proton Therapy Center; $185 Million Facility to Offer Advanced Care to Cancer Patients  
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: